Prostatic Neoplasms - Immunology
Research News and Information

Tuesday, November 24, 2009

Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.

30 Oct 2009 BACKGROUND: Prostate-infiltrating CD8(+) T lymphocytes (CD8(+) PIL) are prevalent in men with prostate cancer (PCa), however, it is unclear whether the presence of such cells reflects a non-specific immune infiltrate or an oligoclonal, ... Read more...

A novel model of bone-metastatic prostate cancer in immunocompetent mice.

30 Oct 2009 BACKGROUND: Bone metastasis is a frequent and catastrophic consequence of prostate cancer for which only palliative treatment is available. Animal models of bone metastatic prostate cancer are necessary for understanding disease mechanisms but few ... Read more...

Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.

13 Oct 2009 We previously reported that naive, tumor-specific CD8(+) (TcR-I) T cells transferred into prostate tumor-bearing mice traffic to the prostate where they become tolerized. We now report that TcR-I cells suppress the proliferation of naive T cells. ... Read more...

Latest indexed articles for 'Prostatic Neoplasms - Immunology'

These are the very latest articles for this heading:

• Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+. 30 Oct 2009
• A novel model of bone-metastatic prostate cancer in immunocompetent mice. 30 Oct 2009
• Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells. 13 Oct 2009
• Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells. 19 Sep 2009
• Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. 13 Sep 2009
• Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer. 13 Sep 2009
• Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients. 13 Sep 2009
• Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus. 2 Sep 2009
• Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells. 30 Aug 2009
• Prostate cancer screening; is this a teachable moment? 29 Aug 2009
• Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. 29 Aug 2009
• Contemporary risk profile of prostate cancer in the United States. 25 Aug 2009
• CD4+ lymphocytes modulate prostate cancer progression in mice. 13 Aug 2009
• PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer. 10 Aug 2009
• Numbers needed to decide. 9 Aug 2009
• Public knowledge of benefits of breast and prostate cancer screening in Europe. 9 Aug 2009
• [Prostate cancer screening: no proof of the benefit] Aug 2009
• A feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard. 30 Jul 2009
• Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo. 30 Jul 2009
• Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer. 25 Jul 2009

See a longer list of these articles.

Technical information about 'Prostatic Neoplasms'

Definition: Tumors or cancer of the PROSTATE.

Descriptor UI: D011471

Alternative terms: Prostatic Neoplasms; Neoplasms, Prostate; Neoplasm, Prostate; Prostate Neoplasm; Neoplasms, Prostatic; Neoplasm, Prostatic; Prostatic Neoplasm; Prostate Neoplasms; Prostate Cancer; Cancer, Prostate; Cancers, Prostate; Prostate Cancers; Cancer of the Prostate; Prostatic Cancer; Cancer, Prostatic; Cancers, Prostatic; Prostatic Cancers; Cancer of Prostate;

Related Mesh Headings: Prostatic Hyperplasia; Prostate-Specific Antigen;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secondary; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04.588.945.440.770; C12.294.260.750; C12.294.565.625; C12.758.409.750;

Technical Notes: coordinate IM with histological type of neoplasm (IM); note PROSTATIC ADENOMA see PROSTATIC HYPERPLASIA is also available